As of 2026-09-19, the Relative Valuation of bluebird bio Inc (BLUE) is (487.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -9902.6%.
The range of the Relative Valuation is (427.34) - (553.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 27.1x | 23.8x |
| Forward P/E multiples | 19.0x - 27.6x | 23.9x |
| Fair Price | (427.34) - (553.58) | (487.19) |
| Upside | -8698.3% - -11238.4% | -9902.6% |
| Date | P/E |